Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Sep;72(3):752–756. doi: 10.1038/bjc.1995.405

Childhood T-cell lymphoblastic lymphoma--does early resolution of mediastinal mass predict for final outcome? The United Kingdom Children's Cancer Study Group (UKCCSG).

S F Shepherd 1, R P A'Hern 1, C R Pinkerton 1
PMCID: PMC2033893  PMID: 7669589

Abstract

This study presents a retrospective review of chest radiography in children with Murphy stage III T-cell lymphoblastic lymphoma. All received a standard leukaemia-based protocol with intensive induction, consolidation and continuing chemotherapy. Neither initial thoracic disease bulk nor the presence of a pleural effusion predicted outcome. However a significant difference was found when the 50 patients in whom the chest radiograph returned to normal within 60 days of commencing treatment were compared with the 18 patients with persistent mediastinal abnormalities, for both event-free [hazard ratio < or = 60 days to > 60 days (HR) 3.55 (95% CI 1.33-9.48); P = 0.007] and overall survival [HR 2.95 (95% CI 1.07-8.18); P = 0.03]. It appears that this relatively simple estimate of chemosensitivity may identify a group of particularly good-risk patients in whom drugs associated with late morbidity such as anthracyclines may be reduced and conversely a higher risk group in whom further intensification of treatment would be justified.

Full text

PDF
752

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger R., Le Coniat M., Vecchione D., Derré J., Chen S. J. Cytogenetic studies of 44 T-cell acute lymphoblastic leukemias. Cancer Genet Cytogenet. 1990 Jan;44(1):69–75. doi: 10.1016/0165-4608(90)90199-k. [DOI] [PubMed] [Google Scholar]
  2. Camitta B. M., Lauer S. J., Casper J. T., Kirchner P. A., Kun L. E., Oechler H. W., Adair S. E. Effectiveness of a six-drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children. Cancer. 1985 Aug 15;56(4):738–741. doi: 10.1002/1097-0142(19850815)56:4<738::aid-cncr2820560406>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  3. Crist W. M., Shuster J. J., Falletta J., Pullen D. J., Berard C. W., Vietti T. J., Alvarado C. S., Roper M. A., Prasthofer E., Grossi C. E. Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group Study. Blood. 1988 Dec;72(6):1891–1897. [PubMed] [Google Scholar]
  4. Eden O. B., Hann I., Imeson J., Cotterill S., Gerrard M., Pinkerton C. R. Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503. Br J Haematol. 1992 Oct;82(2):310–316. doi: 10.1111/j.1365-2141.1992.tb06423.x. [DOI] [PubMed] [Google Scholar]
  5. Lange B. J., Raimondi S. C., Heerema N., Nowell P. C., Minowada J., Steinherz P. E., Arenson E. B., O'Connor R., Santoli D. Pediatric leukemia/lymphoma with t(8;14)(q24;q11). Leukemia. 1992 Jul;6(7):613–618. [PubMed] [Google Scholar]
  6. Mott M. G., Chessells J. M., Willoughby M. L., Mann J. R., Morris-Jones P. H., Malpas J. S., Palmer M. K. Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG). Br J Cancer. 1984 Oct;50(4):457–462. doi: 10.1038/bjc.1984.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. North L. B., Fuller L. M., Sullivan-Halley J. A., Hagemeister F. B. Regression of mediastinal Hodgkin disease after therapy: evaluation of time interval. Radiology. 1987 Sep;164(3):599–602. doi: 10.1148/radiology.164.3.3112862. [DOI] [PubMed] [Google Scholar]
  8. Pui C. H., Behm F. G., Singh B., Schell M. J., Williams D. L., Rivera G. K., Kalwinsky D. K., Sandlund J. T., Crist W. M., Raimondi S. C. Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood. 1990 Jan 1;75(1):174–179. [PubMed] [Google Scholar]
  9. Shuster J. J., Falletta J. M., Pullen D. J., Crist W. M., Humphrey G. B., Dowell B. L., Wharam M. D., Borowitz M. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1990 Jan 1;75(1):166–173. [PubMed] [Google Scholar]
  10. Weinstein H. J., Cassady J. R., Levey R. Long-term results of the APO protocol (vincristine, doxorubicin [adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma. J Clin Oncol. 1983 Sep;1(9):537–541. doi: 10.1200/JCO.1983.1.9.537. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES